The Ministry of Health and Welfare recently amended the "Measures for the Administration of Drug Safety Surveillance" (formerly known as the Measures for the Administration of Drug Safety Surveillance) to expand and standardize all drug license holders to establish a drug safety surveillance mechanism. In addition, in order to ensure the integrity of drug safety surveillance data Therefore, drug manufacturers should write their safety monitoring data and reports to strengthen the safety monitoring of drugs after they go on the market in my country, and implement the drug safety monitoring system in my country, which will be implemented on January 1, 2023.
Please refer to the link: FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease | FDA
Please refer to the link: FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease | FDA